Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China · Delayed Price · Currency is CNY 22.52
+0.31 (1.40%)
Sep 30, 2026, 3:00 PM CST
SHA:600993 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 631.23 | 2,088 | 3,015 | 2,988 | 2,494 | 2,431 |
Short-Term Investments | 30.04 | 0.45 | - | - | 138.81 | 142.01 |
Trading Asset Securities | 1,846 | 506.09 | 142.14 | 63.29 | 674.35 | 106.02 |
Cash & Short-Term Investments | 2,507 | 2,594 | 3,157 | 3,051 | 3,307 | 2,679 |
Cash Growth | -15.50% | -17.84% | 3.48% | -7.72% | 23.45% | 15.22% |
Accounts Receivable | 767.01 | 796.97 | 457.05 | 334.67 | 409.64 | 242.87 |
Other Receivables | 42.44 | 32.91 | 36.51 | 42.57 | 44.98 | 24.94 |
Receivables | 809.45 | 829.88 | 493.56 | 377.24 | 454.62 | 267.81 |
Inventory | 268.19 | 320.87 | 277.63 | 273.48 | 336.2 | 313.92 |
Other Current Assets | 95.38 | 62.37 | 46.53 | 69.48 | 128.18 | 100.85 |
Total Current Assets | 3,680 | 3,807 | 3,975 | 3,772 | 4,226 | 3,361 |
Property, Plant & Equipment | 734.59 | 735.98 | 770.89 | 635.53 | 515.34 | 440.44 |
Long-Term Investments | 1,004 | 570.9 | 148.95 | 152.83 | 151.47 | 176.79 |
Goodwill | 22.99 | 22.99 | 25.26 | 25.26 | 25.26 | 25.26 |
Other Intangible Assets | 108.46 | 114.06 | 93.09 | 90.11 | 37.28 | 36.9 |
Long-Term Deferred Tax Assets | 57.09 | 54.55 | 50.59 | 49.46 | 58.36 | 21.63 |
Long-Term Deferred Charges | 130.19 | 119.97 | 113.4 | 82.3 | 66.52 | 58.44 |
Other Long-Term Assets | 14.44 | 10.41 | 4.6 | 22.46 | 8.14 | 6.27 |
Total Assets | 5,752 | 5,436 | 5,182 | 4,830 | 5,088 | 4,127 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 309.06 | 318.2 | 337.66 | 289.69 | 284.74 | 156.82 |
Accrued Expenses | 142.28 | 161.9 | 69.53 | 105.15 | 118.5 | 141.79 |
Short-Term Debt | 11 | 11 | 31.8 | 45.8 | 88.1 | 88 |
Current Portion of Long-Term Debt | - | - | 107.79 | 9.79 | - | - |
Current Portion of Leases | 21.5 | 17.81 | 18.43 | 23.12 | 28.13 | 21.14 |
Finance Div. Other Current Liabilities | 12.76 | 22.24 | 19.29 | - | - | - |
Current Income Taxes Payable | 54.42 | 60.65 | 67.2 | 36.24 | 70.98 | 60.42 |
Current Unearned Revenue | 92.88 | 99.74 | 88.65 | 91.86 | 102.75 | 88.18 |
Other Current Liabilities | 401.19 | 76.11 | 64.01 | 79.43 | 164.94 | 109.08 |
Total Current Liabilities | 1,045 | 767.64 | 804.36 | 681.07 | 858.14 | 665.44 |
Long-Term Debt | - | - | - | 100 | 400 | - |
Long-Term Leases | 60.98 | 70.31 | 76.2 | 93.59 | 122 | 73.21 |
Long-Term Unearned Revenue | 49.97 | 55.42 | 54.56 | 27.89 | 26.95 | 29.03 |
Long-Term Deferred Tax Liabilities | 23.28 | 22.09 | 23.5 | 28.61 | 35.37 | 2.51 |
Other Long-Term Liabilities | 5.91 | 6.02 | 22.04 | 28.46 | 29.54 | 42.53 |
Total Liabilities | 1,185 | 921.49 | 980.66 | 959.62 | 1,472 | 812.72 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 431.05 | 431.05 | 431.05 | 431.05 | 431.05 | 431.05 |
Additional Paid-In Capital | 23.62 | 23.41 | 23.53 | 51.51 | 100.74 | 105.2 |
Retained Earnings | 3,984 | 3,923 | 3,608 | 3,253 | 2,960 | 2,634 |
Comprehensive Income & Other | 2.11 | 2.62 | 2.96 | 2.66 | 2.46 | 1.28 |
Total Common Equity | 4,440 | 4,380 | 4,066 | 3,738 | 3,495 | 3,171 |
Minority Interest | 126.22 | 135.01 | 135.32 | 131.94 | 121.5 | 142.82 |
Shareholders' Equity | 4,567 | 4,515 | 4,201 | 3,870 | 3,616 | 3,314 |
Total Liabilities & Equity | 5,752 | 5,436 | 5,182 | 4,830 | 5,088 | 4,127 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 93.48 | 99.13 | 234.22 | 272.29 | 638.23 | 182.35 |
Net Cash (Debt) | 2,414 | 2,495 | 2,923 | 2,779 | 2,669 | 2,496 |
Net Cash Growth | -12.69% | -14.64% | 5.19% | 4.14% | 6.90% | 13.90% |
Net Cash Per Share | 5.59 | 5.79 | 6.81 | 6.46 | 6.19 | 5.80 |
Filing Date Shares Outstanding | 431.05 | 431.05 | 431.05 | 431.05 | 431.05 | 431.05 |
Total Common Shares Outstanding | 431.05 | 431.05 | 431.05 | 431.05 | 431.05 | 431.05 |
Working Capital | 2,635 | 3,040 | 3,171 | 3,091 | 3,368 | 2,696 |
Book Value Per Share | 10.30 | 10.16 | 9.43 | 8.67 | 8.11 | 7.36 |
Tangible Book Value | 4,309 | 4,243 | 3,948 | 3,623 | 3,432 | 3,109 |
Tangible Book Value Per Share | 10.00 | 9.84 | 9.16 | 8.40 | 7.96 | 7.21 |
Buildings | 618.97 | 617.08 | 289.57 | 290.61 | 293.35 | 290.37 |
Machinery | 473.14 | 467.86 | 447.54 | 401.77 | 402.1 | 292.67 |
Construction In Progress | 30.77 | 14.79 | 357.6 | 205.74 | 25.71 | 8.75 |